Niche Focus Leverage TopoGEN's specialized topoisomerase assay kits and cell-based screening services to target cancer drug discovery programs and antibacterial research, offering a turnkey mechanism-based solution that differentiates from larger generic suppliers.

In-House Screening Promote the in-house, mechanism-based screening capability as a premium service for pharma and biotech partners seeking discovery-grade topoisomerase modulators, with a emphasis on protein targets and cellular context.

Global Support Highlight long-standing international client relationships and dedicated data interpretation and consultation to position as a collaborative research partner, opening opportunities for strategic, multi-year contracts.

Colorado Expansion Leverage the recent office expansion into Colorado to target regional biotech clusters for partnerships, collaborations, and grant-enabled projects, and to emphasize scalability of operations.

Growth & Funding Signals Frame revenue range and lean funding context as a base for conversations about pilot programs, co-development deals, and phased investment opportunities with mid-market biotech firms seeking niche topoisomerase capabilities.